ArticleMetabolites2017

Non-Targeted Metabolomics Analysis of the Effects of Tyrosine Kinase Inhibitors Sunitinib and Erlotinib on Heart, Muscle, Liver and Serum Metabolism In Vivo.

Brian C Jensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.